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AMF: Alternating Magnetic Field 
BBS: Borate buffered saline 
DLS: Dynamic Light Scattering 
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TB: Terrific Broth 
TEM: Transmission Electron Microscopy 
TGA: Thermogravimetric Analysis 
TRIS: Tris(hydroxymethyl)aminomethane 
S-NHS: N-Hydroxysulfosuccinimide 




The synergy between nanotechnology and biological science is being exploited in the 
last years, giving rise to a great amount of knowledge generation and applications in a 
wide variety of fields. This increasing use of this type of nano-sized materials has 
awakened the interest on the interaction between them and biological entities: cells, 
tissues or organisms. Among all the types of available nanomaterials, iron oxide mag-
netic nanoparticles have shown a huge potential in the biomedical field due to their bio-
compatibility and other interesting properties, especially their ability to produce heat 
when exposed to an external alternating magnetic field. A virtually unexplored subject 
is the interaction of magnetic nanoparticles with cell membranes of living cells. The 
study of this topic will have impact on fundamental science (i.e. biophysical studies of 
the cell membrane under localized heating, changes in heating efficiency of nanoparti-
cles when interacting with living cells) and will allow the development of brand new 
applications (i.e. hyperthermia treatment, cell transfection). 
In the work here presented, E-cadherin has been selected as a targeting agent. It is a 
ubiquitous adhesion protein present in the cell membranes of many cell types, with im-
portant physiological functions and a key role in cancer progression. Spherical magnetic 
nanoparticles have been functionalized with this protein in an oriented manner, so that 
they are able to interact with the homologue proteins in the cell membrane. In that way, 
this is proposed as an approach to immobilize magnetic nanoparticles on the cells sur-
face. Two different strategies were designed, one of them showing promising results of 
the oriented functionalization. However, the efficiency of the process needs to be further 




Resumen en español para público no científico 
Actualmente, nanotecnología y biotecnología son dos disciplinas en auge que aportan 
importantes contribuciones a la ciencia y la sociedad. Más allá de sus aportaciones por 
separado, estas dos áreas de conocimiento presentan una gran sinergia cuando se com-
binan. La nanotecnología trabaja con materiales con un tamaño muy reducido: en el 
orden de los nanómetros, 100.000 veces más pequeños que el grosor de un pelo. Este 
tamaño nanométrico otorga a materiales ampliamente conocidos (como el oro o la mag-
netita) nuevas propiedades que no poseen cuando se encuentran con tamaño macroscó-
pico. Las nanopartículas de oro, por ejemplo, poseen distintos colores dependiendo de 
su tamaño (siempre en el rango de nanómetros), muy distintos al habitual dorado. Así, 
algunas propiedades emergentes pueden ser aprovechadas para distintas aplicaciones. 
En el caso de las nanopartículas magnéticas de óxido de hierro, que podrían considerar-
se diminutos imanes, son capaces de producir calor de manera local cuando se les expo-
ne a un llamado campo magnético alterno, que actúa sin entrar en contacto físico con las 
nanopartículas. Esto permite aplicaciones como la eliminación de células tumorales 
mediante un calentamiento muy localizado utilizando estas nanopartículas magnéticas, 
con una activación externa y no invasiva. Esto además reduciría los efectos secundarios 
al minimizar el daño a tejidos sanos. 
Por esta aplicación explicada y otras de diferentes índoles, resulta interesante conse-
guir que estas nanopartículas magnéticas se unan específicamente a las células que nos 
interesen. Este trabajo se centra en conseguir decorar las nanopartículas con lo que de-
nominaremos piezas de puzle que les permitan encajar y unirse a sus complementarias, 
que estarán presentes en las células. Estas piezas deberán estar unidas con una orienta-
ción adecuada para que pueda encajar con su contrario, y así conseguir que queden in-
movilizadas en las células de una manera específica y localizada, que podrá aprovechar-
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1.1. Nano- and biotechnology 
Nanotechnology is perceived as one of the main revolutions of the 21st century. It 
possesses a huge potential derived from the wide variety of materials and diversity of 
new properties emerging from the nanoscale dimension.1,2 The increasing control of the 
synthesis and functionalization of materials with smaller size broadens the scope of this 
scientific field, becoming more and more multidisciplinary. One of the main symbiosis 
– with biological sciences – has given rise to a brand new field, known as bionanotech-
nology.3–6 The aim of this area is to use different nanomaterials for all kind of biological 
applications, from biomedicine and biosensing to industrial biotechnological produc-
tion. The result of the synergy between both disciplines can be found in a wide range of 
applications. Food industry has long taken advantage of nanoemulsions7, and medicine 
has plenty of examples in which nanotechnology is involved, especially in cancer treat-
ment8–11. Fundamental research has also been provided with new tools from the nano-
technology world, such as the atomic force microscopes, that allow the study of bio-
physical properties of a single biomacromolecule (i.e. a protein)12 or the formation of 
artificial monolayers to study the properties of biological membranes13. 
1.2. Magnetic nanoparticles and hyperthermia 
Magnetic nanoparticles (MNPs) are composed of a magnetic material (most com-
monly iron oxide or a doped iron oxide)14,15 and their size is below 100 nm in all their 
dimensions. MNPs – and especially those composed of iron oxides, magnetite and ma-
ghemite – have an increasing number of applications in the biomedical field due to their 
biocompatibility, stability, non-toxicity and their superparamagnetism at small 
sizes.14,16,17 
One of the most interesting properties of MNPs is their ability to produce heat when 
exposed to an external alternating magnetic field (AMF), process known as magnetic 
hyperthermia. In the case of superparamagnetic MNPs, this is mainly due to two mech-
anisms: Brownian and Néel relaxation. The first one consists of the physical rotation of 
the nanoparticle to orient towards the direction of the external magnetic field. In the 
Néel relaxation, the nanoparticle does not move and the magnetic moment itself rotates 
to orient in parallel with the field direction.18–20 
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Much research has been done focusing on the application of these MNPs in the 
treatment of cancer as hyperthermia has shown a great potential both alone and in com-
bination with other treatments.21–26 In fact, most of the applications developed for this 
type of nanoparticles are related to cancer treatment27 or drug delivery following differ-
ent strategies28. 
1.3. Interaction of magnetic nanoparticles with cell membranes 
The interaction between nanomaterials and living organisms has long been an area of 
interest. It stands in a position where fundamental and applied research meet, as the un-
derstanding of how a specific nanomaterial interplays with a cell, or how an organism 
responds to its presence, promotes the appearance of new applications for these nano- 
sized materials. Regarding that, many toxicity studies of MNPs have been performed 
both in vitro and in vivo.28 
Nevertheless, toxicity, although crucial, is not the only aspect worth studying of the 
relationship between nanomaterials and living systems. The interaction of nanomaterials 
with the cell membrane is related with the cellular uptake and can trigger signalling pro-
cesses. Besides, the heating efficiency of MNPs varies when they are interacting with 
cells. The Brownian relaxation contribution to heat generation decreases dramatically in 
highly viscous environments or when something (i.e. a covalent bond or the interaction 
with large biological structures such as the cell membrane) impedes the physical rota-
tion. Therefore, the location of the MNPs – extracellular matrix, cell membrane or cyto-
sol – highly influences the heating efficiency, as Di Corato et al. demonstrated in their 
work with fixed cells.29 It would be convenient to study the influence of the interaction 
of MNPs with living cells on their heating efficiency. However, although it is easy to 
have a model of internalized MNPs, retaining them on the cell membrane is particularly 
challenging. It is relatively straightforward to functionalize MNPs to target cell mem-
brane receptors (i.e. with antibodies as targeting agents), but the constant renewal and 
exchange of those biomolecules or a triggered endocytosis can promote MNP internali-
zation sooner than desired.30,31 
Attaching MNPs to the cell membrane without triggering active uptake mechanisms 
would not only permit the study of their heating efficiency but would also provide a 
resourceful tool for other fundamental studies such as biophysical studies of the cell 
membrane under localized heating. In addition, being able to gain control on the genera-
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tion of long-lived hotspots on the membrane could allow the formation of reversible 
pores, useful for the intracellular delivery of biomolecules such as proteins or DNA – 
therefore, giving birth to a universal tool for transfection. 
Our group is currently working on the immobilization of MNPs on the cell mem-
branes through different strategies. One of the strategies being used to target the cell 
membrane is focused on the use of covalent chemistry, namely biorthogonal click chem-
istry.32 In this case, our preliminary result indicate that the probe used to target the cell 
membrane remains there for approximately 8 hours (J. Idiago-López et al., in prepara-
tion), enough time to perform measurements of the effect of the application of an AMF. 
The work here presented is based on the use of another strategy: non-covalent targeting 
of the cell membrane involving adhesion proteins, concretely cadherins. 
1.4. Cadherins to target the cell membrane 
Cadherins constitute a superfamily of cell-adhesion molecules with a crucial role in 
maintaining cell and tissue structure, and in cellular movement. They are also pivotal in 
morphogenesis during animal development. Among them, classic cadherins are homo-
philic Ca2+-dependent cell-cell adhesion macromolecules, and integrate members such 
as E-, N- and P- cadherins. The extracellular part of these proteins – by which they in-
teract with each other – is spatially structured in five domains (referred to as EC1-5). 
When adjacent cells contact each other, cadherins from the opposing cells located at the 
site of contact form trans-bonds across the interphase. Once those bonds are arranged, 
cadherins can regulate the formation of the cell-cell contact in three different ways: by 
reducing the local interfacial tension directly – through adhesion tension – and indirect-
ly – through signalling towards the actomyosin cytoskeleton, as well as by establishing 
the mechanical coupling of the contacting cells.33 On the intracellular part, the cadherin 
domains interplay with signalling proteins of different pathways: Wnt/β-catenin, Rho-
GTPases, citoplasmatic kinases, etc.34,35 Figure 1 represents a scheme on a tight junc-
tion, the role of cadherins and the connection with structural and signalling molecules. 
Apart from their function in the mentioned physiological processes, cadherins are 
important in cancer progression. The epithelial-mesenchymal transition (EMT) is a pro-
cess through which epithelial cells lose their cell polarity and cell-cell adhesion capaci-
ty. When a tumour undergoes the EMT, it transforms from quiescent to metastatic. This 
is partially due to a change in cadherins expression: E-cadherin (characteristically ex-
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pressed in adult organisms) expression decreases and N-cadherin (present only during 
embryonic development) expression is induced. This switch leads to loosening of inter-
cellular junctions, allowing tumour cells to escape from their original tissue and mi-
grate, originating metastasis.36 
 
Figure 1. Scheme of a tight junction between two adjacent cells, showing the extracellular interaction of 
the cadherins and the interplay with the structural and signalling molecule intracellularly. Adapted from 
Roy and Berx, 2008. 
Although cadherins analysis is always present in cancer research, there is no much 
work taking advantage of their spatial location within cells to target the cell membrane. 
Some studies show the loading of polymeric nanoparticles with vascular endothelial 
cadherin for anticoagulation purposes37, use aptamers of E-cad to deliver drugs38, or 
functionalize MNPs with anti-cadherin 11 antibodies as immunotargeting39. The latter 
strategy resembles the concept of the present work. 
Our idea of attaching MNPs to the cell surface requires targeting a ubiquitous mole-
cule. In this sense cadherins fulfilled this requirement. However, there are multiple clas-
ses of cadherin molecules: classical (type I and II), desmosomal, seven-pass transmem-
brane, large cadherins of the fat and dachsous group and protocadherins.35 Cells con-
taining a specific cadherin subtype tend to cluster together by homophylic interaction 
excluding cells containing other cadherin subtypes. 
Particularly, in our work we have focused our efforts on the development of MNPs 
for targeting E-cadherin expressing cells. E-cad is one of the first characterized cadher-
ins. It is the prototype of type I classical cadherins, group where N- and DE-cadherin 
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can also be found. Therefore, it presents most of the properties and characteristics men-
tioned when the whole family was presented. Many studies have enlightened the struc-
ture, the transcript processing, function, signalling pathway involved, etc.40  
 
Figure 2. Model interaction of two human E-cad EC1-2 domains (PDB 2O72). Blue dots are Ca2+ ions. 
Adapted from Roy and Berx, 2008. 
As our objective is to mimic the homophylic interaction between two E-cad express-
ing cells for ensuring a long-live attachment of MNPs to the cell membrane, it is crucial 
to understand the interaction between two E-cad molecules. As it is shown in Figure 2, 
this interaction is Ca2+-dependant and takes place between the two outer domains of the 
N-terminal (EC1-2) of each identical protein.35,40 Previous work have shown that the 
use of recombinant fragments containing this two outer domains (EC1-2) is enough to 
establish stable homophylic interactions between microspheres and surfaces functional-
ized with E-cadherin fragments.41,42 Besides, unpublished previous results of Helene 
Feracci (collaborator of our group) showed that by using EC1-2 mutants (W2A) it is 
possible to target E-cadherin expressing cells while avoiding the internalization of the 
targeting particle.  
All these previous results encouraged us to optimize the functionalization of magnet-
ic nanoparticles with E-cad EC1-2 recombinant fragments with the ultimate goal of 
generating long-lived hotspot at the cell membrane triggered by AMF. However, this is 
a challenging task, as it would be necessary to ensure an oriented binding of the frag-
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ments as well as to achieve a multivalent binding to the target cells and colloidal stabil-
ity of the functionalized MNPs in cell-culture media.  
As the interaction between two E-cad depends on a correct spatial position, the orien-
tation of the protein domains on the nanoparticle surface is crucial for a correct attach-
ment to the cell membrane. In general, the random functionalization – that is, with no 
control of the orientation – of nanoparticles with proteins is straightforward. However, 
the difficulty increases when the position or orientation of the biomolecule is important 
for the application. Studies where cadherins are used to target cells are based on the 
random functionalization of microspheres41,43 because the contact surface between the 
cell and the microparticle is larger. Therefore, there will be statistically enough protein 
molecules with the correct orientation to establish the binding. However, nanoparticles 
show a dramatically smaller contact area, so it is logical to assume that a good orienta-
tion of all the molecules is required to ensure a multivalent union that secure the binding 
to the cell membrane. The adhesion junction of cells is composed by interspaced clus-
ters of less than ten cadherin molecules (with a median of 6).44 
A similar challenge has been encountered for the functionalization of nanoparticles 
with antibodies. In this case, modifying the pH conditions during the functionalization 
can help to obtain the desired orientation due to ionic interactions previous to the cova-
lent binding. Thus, the availability of the antigen-recognition domain increases.39,45 In 
the present work, due to the small size of the recombinant cadherin fragments, a more 
universal strategy is needed. A widespread methodology in the protein research field is 
the metal-chelate affinity chromatography, generally applied to resins, surfaces and big 
polymeric microbeads. Here we adapt this procedure to functionalize MNPs with ori-
ented and immobilized E-cadherin. This work uses a nitrilotriacetic derivative, Nα,Nα-
Bis(carboxymethyl)-L-lysine hydrate (in this manuscript, abbreviated as NTA), to func-
tionalize the MNPs surface. NTA is able to chelate divalent cations such as Cu2+, Ni2+, 
Zn2+ or Co2+, which at the same time will be able to chelate the histidines of the His-tag 
of a recombinant protein.46–48 As we have the EC12 fragments cloned in a pET plasmid 
that introduced a His-tag at the C-terminal end of the fragment, we could use this strate-
gy to ensure their oriented binding to the MNPs. Although this strategy has been used in 
different occasions with other nanoparticles showing promising results49–51 it has never 





The general objective of this work is to optimize the oriented binding of EC1-2 cad-
herin fragments to MNPs through the metal-chelation to the His-tag sequence fused in 
their C-terminus. To achieve this goal, the following specific objectives were estab-
lished: 
1. Synthesis, water transfer and characterization of magnetic nanoparticles. 
2. Expression and purification of recombinant E/EC1-2 cadherin fragments. 
3. Oriented functionalization of magnetic nanoparticles with E-cadherin fragments. 
4. Characterization and analysis of the functionalization. 
 
Scheme 1. Objectives of the project.  
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3.  Experimental section 
3.1. E-cadherin fragments (EC1-2) production 
3.1.1. E-cadherin (EC1-2) expression 
100 mL of Lysogeny Broth (LB) medium with kanamycin (50 µg/mL) were used to 
start a preculture of Escherichia coli BL21 containing a pET plasmid with the E-
cadherin EC1-2 gen (the two outer domains) and a histidine tag at the C-terminal end. 
The plasmid was gifted by Dr. Helene Feracci. This was incubated at 37 ºC and under 
agitation overnight. The next day, a larger culture of 250 mL was prepared, this time 
with Terrific Broth (TB) medium, diluting the first one to get a final optical density 
(OD) of 0.1. The culture was incubated at 37 ºC, and when the culture reached an OD of 
0.6, the inducing agent of the expression was added, isopropyl β-D-1-
thiogalactopyranoside (IPTG). After 2 h of incubation, the culture was centrifuged at 
500 xg for 20 min, at 4 ºC. The supernatant was discarded, and the pellet frozen until 
the extraction of the protein. 
3.1.2. E-cadherin extraction and purification 
E-cadherin expressed in E. coli forms inclusion bodies, so in order to extract and pu-
rify the protein, it was denaturalized with urea and renaturalized again by slowly remov-
ing the denaturizing agent. The lysis buffer is composed by urea (4 M), Na2HPO4 (50 
mM), imidazole (20 mM) and β-mercaptoethanol (20 mM) and a protease inhibitor 
(Protease Inhibitor Cocktail for use in purification of Histidine-tagged proteins, DMSO 
solution; Ref: P8849-1ML). The pellet obtained from the E-cad expression was resus-
pended in the lysis buffer in an ice bath (to better inhibit the protease activity) and incu-
bated at 4 ºC for 20 min under light magnetic agitation. The suspension was then centri-
fuged (10,000 xg, 30 min), and the pellet discarded. 
To purify the protein, it was attached to agarose beads with NTA-Ni2+ (QIAGEN, 
Ref. 30430) on the surface. This allowed the specific union of the histidine tags. The 
beads were washed twice with the urea buffer (lysis buffer without the protease inhibi-
tor), and twice with the lysis buffer. Then, then supernatant of the protein extraction was 
incubated with the beads (6 mL of agarose beads per 250 mL of bacteria culture) for 2 
h, at 4 ºC in a rotating wheel. After that, the beads were centrifuged (3000 xg, 15 min), 
the supernatant discarded, and the beads washed six times with urea buffer. The result-
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ing beads were dialysed against a decreasing urea gradient: 3 M, 2 M, 1 M, and finally 
several dialysis steps with PBS + β-mercaptoethanol were performed. This slow de-
crease in urea concentration allows the protein to fold correctly. The beads with the E-
cad were stored at 4 ºC in PBS buffer with 0.05% sodium azide to avoid microorgan-
isms or fungus growth (a total volume of around 20 mL). 
3.1.3. Trypsin sensitivity assay 
When E-cad (EC1-2) is correctly folded, it presents resistance towards trypsin cleav-
age when there is Ca2+ present in the media due to structural modifications. However, in 
absence of calcium ions, it is susceptible to proteolysis. This is more detailed in the 
“Results and discussion” section.52 
Procotol 
The amount of agarose beads containing 30 µg of E-cad fragments were washed in 
buffers containing CaCl2 (presence of Ca
2+) or EDTA (absence of Ca2+). Then, the pro-
tein was eluted with imidazole (0.25 M) and each sample incubated with trypsin-
agarose (Sigma, T4019-50UN). After 1 h of incubation at 37 ºC, the trypsin-agarose 
was removed through a miniSpin column filter, and the resulting samples loaded in a 
SDS-PAGE. 
3.2. Nanoparticle synthesis and characterization 
3.2.1. Water transfer of hydrophobic MNPs 
The fundamentals of this step will be further explained in the “Results and discus-
sion” section. 
Protocol32,53 
140 mg of PMAO (MW: 30-50 kDa) were dissolved in 15 mL of CHCl3 in a 500 mL 
flask. Afterwards, 2 mg of TAMRA dissolved in 2 mL ethanol were added, and the re-
action was kept overnight in the dark, under magnetic stirring. The next day, the equiva-
lent to 10 mg of iron in MNPs, dispersed in organic media were washed three times 
with ethanol using a permanent magnet. After the last washing step, the MNPs were 
dispersed in 2 mL CHCl3. To the previously prepared PMAO-TAMRA solution, 81 mL 
of CHCl3 were added, and the MNPs were added drop-wise in an ultrasound bath, 
achieving a final volume of 100 mL. In this step, the polymer coats the MNPs through 
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the hydrophobic interactions between the aliphatic chains of the PMAO and the oleic 
acid ligands present on the MNP surface. 
The most part of the organic solvent was removed using a rotary evaporator at 40 ºC 
and 200-400 mbar. 5-10 mL were left, to which 15 mL of deionized water and 15 mL of 
NaOH (0.1 M) were simultaneously added. The hydrolysis of the anhydride groups of 
the PMAO results in carboxyl groups that stabilize the MNPs in aqueous media. The 
remaining organic solvent was further removed in the rotary evaporator at 70 ºC and 
200 mbar. The resulting MNPs suspension was filtered using 0.2 µm filters to eliminate 
polymer and MNPs aggregates. Finally, the excess of polymer not bound to the MNPs 
was eliminated by four ultracentrifugation steps at 70,000 xg for 2 hours each; the first 
two at room temperature, the following ones at 14 ºC. 
3.2.2. Iron concentration determination 
The reactions, functionalizations and experiments using MNPs were performed by 
iron mass. Therefore, after each step, the iron concentration had to be determined. 
Protocol 
The iron concentration was obtained by a spectrophotometric method using Tiron 
(1,2-dihydroxybenzene-3,5-disulphonic acid). This molecule forms a complex with iron 
that absorbs light at 480 nm. A calibrating curve was performed with Fe(III) solutions 
of known concentrations (0, 100, 200, 400, 600 and 800 µg/mL). For the preparation of 
the MNP samples, 5 µL of MNP suspension were diluted in 45 µL of milliQ water or 
hexane, depending on their hydrophilic or hydrophobic behaviour. All samples were 
treated in triplicate. 
50 µL of each sample were transferred to Eppendorf tubes and each sample was in-
cubated with 100 µL of aqua regia (HCl:HNO3, 3:1) for 15 min at 60 ºC in order to dis-
solve the iron of the MNPs. Afterwards, 350 µL of milliQ water were added to stop the 
reaction, and 50 µL of each solution were transferred to a 96-well plate. To each well, 
100 µL of Na3PO4 (0.2 M, pH 9.7) and 60 µL of a solution of 50 µL KOH (4M) and 10 
µL Tiron (0.25M) previously prepared were added. The plate was incubated for 15 min 




3.2.3. Electrophoresis in agarose gels 
Electrophoresis allows the identification of charge and mass changes that MNPs un-
dergo, as less free carboxyl groups remain after each functionalization step. Besides, 
this technique is also useful for visualizing the unbound polymer in the water transfer 
step by loading the supernatants from each washing step. 
Protocol 
1% (m/v) agarose gels were prepared using a tris(hydroxymethyl)aminomethane 
(TRIS), borate, EDTA (TBE) 0.5X buffer. Samples were mixed with loading buffer: 
glycerol 25% in TBE (0.5X). The total volume loaded in each well was 8 µL, and the 
ratio sample:buffer varied according to the concentration of the sample. The electropho-
resis was set at 90 V, 45 min. 
3.2.4. Thermogravimetric analysis 
Thermogravimetric analysis (TGA) is a technique that measures the weight differ-
ence of a sample as the temperature increases in a controlled atmosphere. It allows to 
detect the weight variation that usually occurs in reactions such as decompositions, sub-
limations, reductions, desorption, absorption, etc. With this methodology, the organic 
coating of the MNPs can be quantified, and the number of carboxyl groups per nanopar-
ticle can also be estimated. 
Protocol 
A Universal V4.5A TA Instrument equipment was used for the measurements of 
weight against temperature. The quantification of organic material loss was performed 
by heating the samples in air, increasing the temperature at a rate of 10 ºC/min until a 
final temperature of 800 ºC. Organic samples were previously dried in air, and aqueous 
samples were freeze dried. 
3.2.5. Transmission Electron Microscopy (TEM) 
A Tecnai T20 (FEI) was used, with a thermoionic emission gun and operating at a 
voltage of up to 200 kV (Laboratorio de Microscopías Avanzadas, University of Zara-
goza). For the visualization, the sample is prepared over a copper grid covered with car-
bon (Electron Microscopy Sciences). 5 µL of the sample – previously diluted – are de-
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posited on the grid and left to dry in air. Size distribution was analysed with ImageJ 
software. 
3.2.6. Dynamic Light Scattering (DLS) 
Dynamic Light Scattering is a spectroscopic technique used to measure the hydrody-
namic diameter of molecules, particles or colloids in solution. The samples were pre-
pared in water at a final concentration of 0.05 mg Fe/mL, with a final volume of 1 mL. 
The pH was adjusted to 7 for all samples, and each sample measured 5 times at 25 ºC in 
a Malvern Zetasizer equipment, irradiating the samples with a monocromatic helium-
neon laser of 633 nm. 
3.2.7. ζ-potential 
ζ-potential is a measurement of the surface charge or surface potential of small parti-
cles. A laser pierces the centre of the sample and a detector collects the dispersed light 
at an angle of 13º. The same samples and measurement equipment were used as for the 
DLS measurement. 
3.3. MNPs functionalization strategies 
3.3.1. Strategy A 
EDC (100 mM) and S-NHS (100 mM) were mixed and incubated for 10 minutes at 
room temperature under agitation in 2-(N-morpholino)ethanesulfonic acid (MES) (50 
mM, pH 6.5). 0.33 mg Fe of PMAO-TAMRA nanoparticles were added to the EDC/S-
NHS mixture. The volume was adjusted to a final value of 1.2 mL by addition of MES. 
The samples were incubated for 30 min under agitation. MNPs were dialysed in 400 mL 
of MES (50 mM, pH 6.5) for 1 h once and then in HEPES (20 mM, pH 8.0) for 1 h 
twice. Then, 182 nmol of NTA-Cu2+ complex were added to the activated MNPs, and 
incubated for 2 h at room temperature under agitation. Then, the remaining activated 
carboxyl groups were blocked with 500 nmol of the blocking agent (TRIS or PEG 750, 
2000 or 5000 Da) for 45 min. Finally, the resulting MNPs were incubated with E-cad 
EC1-2 fragments at different ratios. When imidazole was used, the concentration was 





3.3.2. Strategy B 
In this strategy, the functionalizations were performed in two steps. First, 1 mg Fe of 
PMAO-TAMRA nanoparticles were mixed with 22.26 µmol of PEG (750 Da) and 40 
µmol of EDC were added twice at time 0 and 30 min of the reaction that lasted 3 h 30 
min. Both PEG and EDC were dissolved in Borate buffered saline (BBS) (50 mM, pH 
9.0). Then, eight washes using cellulose membranes (Amicon, Millipore, 100 kDa) were 
performed. 
The second functionalization was similar. 0.5 mg of Fe were mixed with 460 nmol of 
NTA-Cu2+ and 20 µmol of EDC were added twice at time 0 and 30 min of the reaction 
that lasted 3 h 30 min. The volume was adjusted to a final value of 1.2 mL with BBS 
buffer. The excess of reactants was removed by dialysis against HEPES (20 mM, pH 
7.0, 150 mM NaCl), 3 times. Finally, the resulting MNPs were incubated with E-cad 
EC1-2 fragments at different ratios. When imidazole was used, the concentration was 
0.25 M. Samples were centrifuged for 2h, 24,700 xg, 4 ºC. 
3.3.3. Bradford assay54 
To analyse the amount of protein present in the supernatants after incubation of 
MNPs with E-cad, the Bradford assay was performed. 150 µL of the sample were mixed 
with 150 µL of the Bradford reagent, agitated and incubated for 10 min at room temper-
ature. Then, the absorbance was measured at 595 nm. All samples were measured in 




4. Results and discussion 
4.1. E-cadherin (EC1-2) expression and purification 
E-cadherin fragments were expressed in E. coli BL21 strains and purified as detailed 
in the experimental section. The obtained pellet of bacteria was 3 g. When purified, the 
cadherin fragments were immobilized in agarose beads presenting NTA-Ni2+ on the 
surface. As the E-cad fragments presented a His-tag, they were retained on the beads. 
When the protein was eluted for the first time, the ratio protein/beads was determined: 
around 1 mg protein per mL of beads. This meant that the protein obtained was 20 mg 
(for 3 g of pellet, in 500 mL of culture). 
The protein is expressed inside the bacteria in form of inclusion bodies. Therefore, to 
purify them they were denaturalized and re-naturalized again, which is a sensitive pro-
cess. To ensure that the folding was correct after purification, a trypsin sensitivity assay 
was performed. When the E-cad fragments are correctly folded, they are resistant to 
trypsin cleavage in presence of Ca2+ ions. However, they are sensitive to the cleavage 
without the calcium.52 Figure 3 shows the results when the samples were loaded in 
SDS-PAGE. Both untreated and treated with trypsin in presence of Ca2+ samples 
showed a single band corresponding to the E-cad fragments. However, the sample treat-
ed with trypsin and EDTA (that chelates the metal ions and therefore withdraw Ca2+ 
from the media) was cleaved. These results confirm the correct folding of the protein. 
Furthermore, the SDS-PAGE reflects the high purity of the protein, as no bands are pre-
sent but a single band with the expected size of the fragments (37 kDa) in lane 1. 
 
Figure 3. SDS-PAGE of the samples from the trypsin sensitivity assay. (1) Untreated E-cad fragment. (2) 
E-cad fragment treated with trypsin in presence of Ca2+. (3) E-cad fragment treated with trypsin in pres-
ence of EDTA. 
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4.2. Water transfer of MNPs 
Spherical MNPs of a diameter of 12 nm were used for this work. They were previ-
ously synthesized by Dr. Vanessa Herrero by thermal decomposition method, and their 
size and morphology characterized by TEM (see Annex I). However, the MNPs provid-
ed were not water soluble, as this synthesis technique provides of MNPs dispersed in 
organic media – hexane – and therefore they must be transformed to become water sol-
uble, a requisite for most biological applications. Thus, before starting to optimize their 
oriented functionalization with E-EC1-2 cadherin, it was necessary to perform a water 
transference step using poly(maleic anhydride-alt-1-octadecene) (PMAO) as a coating 
agent (Figure 4). The conditions used were previously optimized in our.32,53 PMAO is 
an amphiphilic polymer with hydrophobic alkyl chains that intercalate between the ole-
ate molecules on the MNP surface. On the other end, PMAO has anhydride groups that 
can be hydrolysed in basic media, leaving free carboxyl groups that will have two main 
purposes: to stabilize the MNPs in aqueous media, and provide reactive groups for fur-
ther functionalizations. In addition, before the hydrolysis of the anhydride groups, the 
polymer was previously modified with a fluorescent probe, tetramethylrhodamine-
cadaverine (TAMRA). Thus, the coating step renders not only water soluble MNPs with 
a high yield (always between 75-100%), but fluorescent MNPs that facilitate future cell-
nanoparticle interaction studies. 
 
Figure 4. Scheme of the water transfer process with the PMAO-TAMRA (1%) polymer. On the left, 
MNPs in organic media with oleate coating. On the right, MNPs coated with the polymer through hydro-
phobic interactions between aliphatic chains and with the anhydride groups of PMAO hydrolysed. The 
structures of the polymer and the fluorophore are shown. 
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Once the process was completed, the polymer excess was removed with four washes 
consisting in ultracentrifugation steps. With an agarose gel electrophoresis, the correct 
elimination of the excess of polymer was confirmed by loading the purified MNPs (Fig-
ure 5, lanes 1-3) and the supernatants from each washing step (Figure 5, lanes 4-7). As 
shown in Figure 5b the polymer, fluorescent under UV light exposure, is completely 
removed after the fourth wash. Besides, Figure 5a compares the electrophoretic mobility 
of different batches of water transferred MNPs with that of previous transfers from the 
same magnetic core synthesis. The identical mobility indicates the correct water transfer 
of the MNPs, as well as the high reproducibility of the method. 
 
Figure 5. Agarose gel (1% m/v) electrophoresis of water transferred MNPs and washes’ supernatants. (a) 
Visible light picture. (b) UV light illuminated picture. (1) Reference MNPs, previously transferred; from 
the same organic batch. (2, 3) Water transferred MNPs. (4, 5, 6, 7) Supernatants of successive washing 
steps. 
For further characterization, a thermogravimetric analysis (TGA) was performed. 
This technique reveals the mass loss of a sample as the temperature increases (Figure 
A2). Therefore, information about the organic layers (oleate and polymeric coating) can 
be obtained. Oleate represented 12.1% of the total mass, whereas the PMAO reached 
almost 30%. With this data, available, the number of carboxyl groups present on the 
MNPs surface could be estimated to be around 4,000 carboxyl groups per nanoparticle 





4.3. Dual functionalization approach of the MNPs: passivation and functionalization 
with NTA-Cu2+ 
The next step was to optimize the functionalization of the PMAO-TAMRA nanopar-
ticles with two functionalities: (1) NTA-Cu2+, that will permit the further union of a His-
tagged protein (E-cadherin, in this case) through its histidine tag; and (2) polyethylene 
glycol (PEG) or TRIS molecules to improve the colloidal stability of the MNPs. 
Carbodiimide chemistry was elected to functionalize the MNPs. Carboxyl groups 
from the nanoparticles surface can react with amine groups present on the molecules to 
be attached. However, carboxyl groups must be activated with 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC). Although it is a highly common reaction in 
organic chemistry, it is quite complex when used in nanotechnology due to possible side 
reactions, especially the hydrolysis of the resulting active intermediate O-acylisourea. 
The pH is key for the yield of the reaction: the amine group of the molecule has to be 
deprotonated (higher pH), but the carboxyl activation is more efficient at slightly acidic 
pH. The addition of N-hydroxysulfosuccinimide (S-NHS) stabilizes the active interme-
diate. Figure 6 represents the main pathways of the EDC chemistry. 
 
Figure 6. Activation of carboxyl groups with EDC chemistry. Formation of the desired amide bond (cir-
cled) and the possible side reactions. 
In this work, two different molecules need to be bound on the MNPs surface. If both 
were added simultaneously while the carboxyl groups are activated, they would com-
pete to react. Therefore, a sequential addition is necessary for a better control of the 
functionalization. The first approach (Strategy A) consisted on the activation of the car-
boxyl groups with EDC/S-NHS in acidic media, addition of the NTA-Cu2+ complex, 
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and subsequent blocking of the remaining activated groups with the passivating mole-
cule (TRIS or different PEG molecules). The second approach (Strategy B) included 
two activation steps: one for the addition of PEG, and the other to functionalize with 
NTA-Cu2+. The latter strategy was performed in alkaline media and with high excess of 
EDC. Figure 7 summarizes both protocols followed to functionalize the MNPs, and a 
more detailed explanation is then provided. 
 
Figure 7. Scheme of the two strategies followed to functionalize MNPs with NTA-Cu2+ and to passivate 
them. In red, the carboxyl groups activated by the carbodiimide. PEG 750 Da is used to illustrate this 
scheme. All the passivation molecules were tested through “Strategy A”. 
4.3.1. Strategy A 
The first strategy proposed (Figure 7, upper part) consisted on a first functionaliza-
tion of MNPs with NTA-Cu2+ complex; the surface of the MNPs is afterwards passivat-
ed with different passivation molecules containing a primary amine group. The com-
plete protocol can be found in the experimental section. Briefly, MNPs were incubated 
with EDC/S-NHS in a slightly acidic buffer to activate the carboxyl groups of the sur-
face. The reaction intermediate is relatively more stable at this pH. After activation, 
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EDC/S-NHS excess was removed via dialysis in order to avoid side reactions of NTA. 
Then, the NTA-Cu2+ complex was added to the activated nanoparticles – the amount 
calculated to functionalize 30% of the carboxyl groups. Finally, the remaining activated 
groups on the MNPs surface were blocked with different molecules: TRIS and CH3O-
PEG-NH2 with different molecular weights (750, 2000 and 5000 Da). 
4.3.1.1. Incubation with E-cad 
MNPs functionalized following strategy A were incubated with increasing ratios of 
E-cad and then centrifuged. The union was quantified by an indirect method, comparing 
the amount of E-cad on the supernatants with the amount of E-cad in the original solu-
tion. Quantification was performed by denaturizing polyacrylamide gel electrophoresis 
(SDS-PAGE) (Figure 8) followed by image analysis (using ImageJ software) and Brad-
ford assay54. For a first trial, only MNPs passivated with TRIS were used. 
  
Figure 8. On the left, silver stained SDS-PAGE of different E-cad/MNPs ratio (from 10 to 250 µg E-
cad/mg Fe), comparing the original E-cad solutions (a) and the supernatants after incubation (b). The 
union quantification was determined by image analysis with ImageJ (A) and Bradford assay (B). On the 
right, saturation curve of the E-cad union (% union vs. E-cad/MNPs ratio) based on the Bradford results. 
The results show a clear difference between E-cad concentration in the original solu-
tion and the supernatants after the incubation with the NTA-Cu2+-functionalized MNPs. 
The SDS-PAGEs were stained with the silver staining protocol. Although it is conven-
ient for low protein amounts due to its low detection limit, silver staining is not the best 
technique to quantify different protein amounts, for the optimal revealing time for cer-
tain concentrations often results in under- or overexposure for others. That is why the 10 
and 25 µg cad/mg Fe conditions could not be observed nor analysed, and the 100 and 
250 cad/mg Fe conditions were overexposed and saturated and the ratio obtained by 
image analysis is not precise nor reliable. However, the image allows to determine qual-
itatively the union of the E-cad that is confirmed and more precisely quantified by the 
Bradford assay. With these data, a saturation curve can be drawn (Figure 8, right), 
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which shows that near the 100 µg E-cad/mg Fe ratio the MNPs do not accept more pro-
tein. 
After those preliminary results, the four different batches of MNPs – each passivated 
with a different molecule of those mentioned before – were compared in terms of union 
efficiency. 50 µg E-cad/mg Fe were used for all cases. In addition, for the E-cad to be 
attached in an oriented manner, the functionalization should occur via chelation effect, 
and no other non-specific unions. To prove that, a new condition was added: all MNPs 
were also incubated with E-cad in the presence of imidazole (0.25 M), a well-known 
competitor of histidine in the chelation equilibrium with divalent metals (Cu2+, Ni2+, 
Co2+).48 
 
Figure 9. Silver stained SDS-PAGE of the original solutions of E-cad (O) and the supernatants after its 
incubation with MNPs passivated with different molecules (TRIS, PEG750, PEG2000, PEG5000) with 
(SN w) or without (SN w/o) imidazole 0.25 M. The union percentages were obtained by image analysis. 
The results shown in Figure 9 reflect in all cases a significant union percentage of the 
protein in all four cases. Besides, the addition of imidazole reduced that union except 
for the PEG5000-passivated MNPs. This is not what was expected, as imidazole was 
supposed to impede the union of the E-cad in all cases, and more dramatically – in the 
best of the cases, there was only a 16% reduction on the binding efficiency. It should be 
taken into account that silver staining is a very sensitive developing technique, and min-
imum variations and errors can influence the result. Besides, as mentioned before, the 
revealing time can be crucial in case the gel bands saturate. A Bradford assay would be 
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needed to check these data, but for this particular experiment the samples were no long-
er available. However, although it cannot be quantified in a precise way, it can be clear-
ly seen that a non-specific binding of cadherin fragments is competing with the affinity 
binding through metal chelation. This deficient functionalization is probably due to the 
deactivation of the carboxyl groups. To remove the excess of EDC/S-NHS, a dialysis 
step is performed; this step takes several hours in which part of the active intermediates 
can be hydrolysed (see Figure 6). With a deficient blocking of the MNPs surface, many 
carboxyl groups would remain free, and that can cause a non-specific union through 
ionic interactions with high positive charge density zones of the E-cad fragments. 
This inefficiency in blocking the remaining carboxyl groups was also confirmed by a 
stability assay with culture media both with and without serum (fetal bovine serum, 
FBS), and the results are shown in Annex III (Figure A3). MNPs were incubated with 
the different media in 1:1 and 1:3 MNP:media volume ratios. Only the 1:3 ratio is 
shown. 
The results show a clear aggregation for all cases when mixed with culture media 
(Dulbecco’s Modified Eagle’s Medium, DMEM) without FBS. DMEM is more com-
plex than simple buffers, and presents a higher ionic strength. Thus, a bad passivation of 
the COOH groups can lead to a loss of a negative net charge of the nanoparticles, losing 
the repulsion and favouring the aggregation. When incubated in the presence of FBS, 
the stability of the MNPs increased dramatically independently of the passivating agent. 
This is most probably due to the formation of the protein corona, a mixture of proteins 
that absorb to the MNPs surface unspecifically due to ionic adsorption to the exposed 
carboxyl groups at the MNPs surface.53 Although this protein corona clearly improves 
the colloidal stability of the E-cad, it might interfere in the future application of the 
functionalized MNPs, blocking sterically the interaction between the E-cad on the 
MNPs surface and the E-cad on the cell membranes. Besides, the formation of the coro-
na indicates a deficient passivation of the surface. Considering that one of the pas-
sivation agents – PEG 750 Da – has been already used in our group and showed a great 
stabilization in MNPs with the same characteristics,32 the protocol used in Strategy A is 
clearly not optimal. Therefore, a different strategy was designed, improving some tech-




4.3.2. Strategy B 
Considering the results of the previous approach, the conditions were optimized in 
strategy B (Figure 7, lower part): (1) only PEG 750 Da was used as passivation agent 
for simplicity purposes, as it had resulted successful in previous works of the group; (2) 
the pH was raised to 9, closer to the pKa of NTA and PEG, increasing the number of 
deprotonated amine groups, and therefore the molecules able to react; (3) diminish the 
deactivation of carboxyl groups eliminating the removal of the EDC excess. This step is 
common with biomolecules that present carboxyl and amine groups simultaneously – to 
avoid crosslinking. However, this PEG does not have a carboxyl groups, and those of 
the NTA molecule are protected as long as they are chelating the metal ion. A more 
detailed description is provided in the experimental section. 
To further ensure that every step was successful, an agarose gel was loaded with the 
water transferred MNPs, the MNPs passivated with PEG, and the ones with NTA-Cu2+ 
(Figure 10). As each functionalization step implies the reaction of carboxyl groups, the 
electrophoretic mobility decreases, for the surface charge is less and less negative after 
each step. It is clear then that the functionalization is correct in both steps, and therefore 
the MNPs have now both the passivating molecule and the linker that will allow the 
oriented functionalization of the E-cad. 
 
Figure 10. Agarose (1% m/v) gel of the different functionalization steps. (a) Visible light picture. (b) UV 
light illuminated picture. (1) Water transferred MNPs. (2) MNPs passivated with PEG 750. (3) MNPs 





4.3.2.1. Incubation with E-cad 
The functionalization strategy was completely different and therefore so was the pro-
tocol, so firstly a new optimization of the E-cad:MNPs ratio was performed. Similarly 
to the previous case, the amount of E-cad was quantified by image analysis and Brad-
ford assay (Figure 11). In both cases, the original E-cad solution was analysed and 
compared with the supernatants of the MNPs incubated with it. The results indicate the 
correct functionalization of the MNPs with E-cad when incubated with the 50 and 100 
μg E-cad/mg Fe ratios. Nevertheless, there are more results worth analysing. 
When incubated with 25 μg E-cad/mg Fe, there is negligible union of protein to the 
MNPs. The amount of protein present in these samples is very low, and the error could 
be high enough not to show significant differences – it should be noted that the absorb-
ance of this particular sample in the Bradford assay is comparable to the blank. The next 
remarkable aspect is the quantification of the union in the presence of imidazole. In the 
SDS-PAGE, it seems to be more protein in the supernatant than in the original solution, 
which is obviously impossible. This experiment should be repeated to evaluate this ob-
servation. However, the Bradford assay shows more logical results. A 9% union of the 
E-cad compared with the 74% with the same protein amount without imidazole demon-
strate that the linkage of the protein takes place through the chelation between the Cu2+ 
and the histidine tag, and unspecific binding of E/EC1-2 fragments was now avoided 
through an efficient passivation. 
 
Figure 11. SDS-PAGE of different E-cad/MNPs ratio (from 25 to 100 µg E-cad/mg Fe), comparing the 
original E-cad solutions (O) and the supernatants after incubation (SN). The union quantification was 
determined by image analysis with ImageJ (A) and Bradford assay (B). An additional condition was 
quantified, with the E-cad remaining from the incubation of the MNPs in the presence of imidazole. 
With the data obtained in this experiment, the number of E-cad molecules per nano-
particle was estimated. The sample with the 25 µg E-cad/mg Fe ratio could be analysed. 
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For the 50 and 100 µg E-cad/mg Fe, the mean was 3 and 4.6 molecules per nanoparticle. 
These results should be improved. For future interaction with cell membranes, to 
achieve a multivalent attachment, the number of protein fragments per nanoparticles 
should be higher. An increase of the NTA-Cu2+ groups or the use of bigger nanoparti-
cles could solve the problem. 
Finally, dynamic light scattering (DLS) and ζ-potential were measured for each func-
tionalization step of strategy B (Table 1). The hydrodynamic diameters obtained for 
each sample were of the same order of magnitude, with small variations caused by the 
modification of the surface. The standard deviation is low in all cases, and the polydis-
persity index is below 0.3 for all samples, which indicated that they were not highly  
aggregated. It is crucial to achieve a correct functionalization and passivation to avoid 
aggregation because, in addition to alter the contact area, the physical properties can 
also be changed (i.e. the heating efficiency). As for the ζ-potential, the results of the 
three first samples are consistent with the agarose electrophoresis: in each functionaliza-
tion step, more carboxyl groups have reacted with molecules, and therefore the net neg-
ative charge decreases. The consequent decrease of the ζ-potential when adding the 
cadherin fragments is consistent, as the net charge of the protein is negative at the pH in 






MNPs@PMAO 136 ± 14 -38 ± 1 
MNPs@PMAO@PEG 111 ± 6 -20 ± 2 
MNPs@PMAO@PEG@NTA-Cu2+ 138 ± 11 -4 ± 1 
MNPs@PMAO@PEG@NTA@E-cad 120 ± 4 -14 ± 1 
Table 1. Measurements of DLS and ζ-potential of the different functionalization steps followed in strate-





Magnetic nanoparticles, and especially iron oxide nanoparticles, have awakened 
great interest in different research fields due to their different properties – biocompati-
bility, stability. The biomedical applications of MNPs are more and more numerous day 
by day, with a special focus in cancer treatment or drug delivery. In this work, we 
sought the modification of these nanoparticles with the aim to attach them to the cell 
membrane. This would allow a new tool for many different applications in hyperther-
mia, biophysical studies, universalized transfection, etc. 
The adhesion protein E-cadherin was selected as a targeting probe for the MNPs, tak-
ing advantage of its homologue interaction and ubiquity in epithelial cells. In order to 
increase the efficiency of union, the strategy of functionalization was designed to con-
trol the orientation of the protein to ensure a multivalent union with the cadherins, oth-
erwise difficult due to the small effective contact area. 
MNPs prepared through thermal decomposition method were successfully trans-
ferred to water in order for them to be water-soluble. This step, involving the coating 
with PMAO polymer, provided the surface of the nanoparticles with carboxyl groups 
that will allow further functionalizations. The approach to attach the E-cad in an orient-
ed manner was to use NTA-Cu2+ to chelate a His-tagged recombinant E-cad (EC1-2). 
Two strategies were followed (A and B). Strategy A, consisting on a first functionaliza-
tion with NTA-Cu2+ using EDC chemistry and the following blocking of the remaining 
activated groups with different passivating agents showed promising results in terms of 
functionalization, but regarding the MNP colloidal stability in physiological media. 
Strategy B used a protocol to obtain stable PEG (750 Da) functionalized MNPs as a first 
step. Then, the remaining carboxyl groups were again activated to functionalize the sur-
face with NTA-Cu2+. That functionalization was successful, and the incubation with E-
cad revealed a good incorporation of the protein, with fair efficiencies at 50 and 100 µg 
E-cad/mg Fe ratios. 
Lastly, the mechanism of union of the protein was determined. For the E-cad to be 
oriented, it should have been bonded via chelating effect of the Cu2+ with the His-tag. 
Imidazole was used as a competitor of the interaction between the divalent cation and 
the protein. In the case of Strategy A, the results were inconclusive and, although it 
showed less union efficiency with MNPs functionalized with three different passivation 
26 
 
agents, that efficiency surprisingly increased with MNPs coated with PEG 5000 Da. 
Regarding Strategy B, the addition of imidazole to the incubation mix highly decreased 
the interaction of the E-cad with the MNPs, therefore confirming a union via chelation. 
However, the theoretical calculation of number of E-cad fragments per nanoparticle 
reflects an insufficient functionalization for the future multivalent attachment to the cell 




6. Future perspectives 
1. Stability assays of E-cad functionalized MNPs 
Test the functionalized MNPs with DMEM with and without FBS to assess the sta-
bility in physiological media. 
2. Cell culture assays: compare MDCK and Balb/c 
To prove the biological activity of the platform here developed, different cell lines 
with distinct cadherin profile expressions should be incubated with the MNPs. In partic-
ular, MDCK cell line (dog kidney) expresses E-cadherin, while Balb/c (mouse hybrid-
oma) does not. Therefore, the nanoparticles should theoretically attach to the former, 
but not to the latter. Besides, more studies could go in depth to the interaction MNPs-
cells, such as the study with the W2A mutant, or the comparison with microbeads to 
study the effect of the contact area and cadherin density. 
3. Time lapse studies: determine how long do MNPs stay on the membrane 
By using the fluorescence of MNPs due to the TAMRA linked to the polymer, stud-
ies using a confocal microscope could determine the location of the MNPs at different 
times. In that way we could study the maximum time the MNPs can stay immobilized 
on the cell membrane. 
4. Hyperthermia studies 
Once the immobilization of the MNPs to the cell membrane is optimized, hyperther-
mia studies would be carried out. The cellular death by different mechanisms (apopto-
sis, necrosis, etc.) should be assessed, as well as the formation of transitory pores. The 
last objective could be studied by using probes of different sizes; evaluating which of 
them are able to pass the cell membrane would allow to determine the size of the pores 
that this system generates. 
5. Future optimization 
In case that future results fail, different parameters should be considered to improve. 
If the attachment to the membrane is not good, larger particles (50-80 nm) could in-
crease the contact area and ease a multivalent interaction. Besides, different sizes and 
shapes of nanoparticles could be tested in order to obtain better heating efficiency, and 
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